The results using a mouse melanoma model are consistent with cohort studies showing that melanoma patients with high CCL21 expression have shorter overall survival (the Human Protein Atlas, https://www.proteinatlas.org/ENSG00000137077-CCL21/pathology/melanoma). Here, CCL21 is linked to melanoma.